The Effect of an Electronic Decision Support System on Preventing Pressure Ulcers and Urinary Infectionsin Home Care
NCT ID: NCT06927479
Last Updated: 2025-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
66 participants
INTERVENTIONAL
2025-09-01
2026-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is planned in two phases. In the first phase, the development of the electronic decision support system to be provided through a mobile-compatible webpage is targeted. In the second phase, a randomized controlled trial will be conducted to assess the usability of the developed decision support system by caregivers.
For the project, patients with a Barthel Index score between 0-20 (if an insufficient number of patients is available, those scoring between 21-61 will also be included) will be selected and divided into intervention and control groups. Caregivers of the intervention group will use the electronic decision support system via a mobile-compatible webpage for eight weeks to receive guidance on preventing pressure ulcers, urinary infection prevention strategies, in-bed mobilization, and nutrition recommendations. Caregivers in the control group will continue with the routine practices of the home healthcare services provided by the Turkish Ministry of Health.
The study outcomes will be evaluated at the beginning and at the ninth week using the Braden Pressure Ulcer Risk Scale, the Ghent Global IAD Classification Tool (GLOBIAD), the ISTAP Skin Tear Classification System, urinalysis (UA), the Urine Color Scale, and the Mini Nutritional Assessment-Short Form (MNA-SF). Additionally, at the end of the study, caregivers in the intervention group will be assessed using the System Usability Scale (SUS-TR), the Mobile Application Usability Scale, the Mobile Application Loyalty Scale, and the Mobile Application Willingness to Use Scale.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CAREGİVER TRAİNİNG AND PRESSURE ULCER PREVENTİON İN HOME CARE
NCT07313046
Determining the Effect of Home Care Training on Anxiety and Depression Levels of Caregivers
NCT07053553
The Effect of Web-Based Training and Counseling Given to Caregivers on the Pressure Injury Risk, Level of Dependence-Independence, and Caregivers' Burden of Care in Bedridden Patients
NCT06832345
The Effect of an Training Program for the Prevention of Pressure Ulcers in Bedridden Patients At Home
NCT06758674
Urinary Catheter Self-care Management
NCT06179238
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
Caregivers in this group will use the electronic decision support system (E-DSS) provided via a mobile-compatible web page. E-DSS will be used to optimize the daily care management of patients and to reduce the risk of pressure ulcers and the risks that predict this risk, such as nutrition and hydration, position changes and in-bed activities. E-DSS will analyze the data obtained from the participants and provide personalized recommendations. Caregivers in the intervention group will receive this training over a period of two weeks, with ongoing support and reinforcement provided throughout the eight-week intervention period via the Electronic Decision Support System (E-DSS).
Training about Electronic Decision Support System
1. System Registration and Usage
2. Pressure Ulcer Prevention
3. Urinary Infection Prevention
4. Nutrition and Hydration Management
5. Physical Activity and In-Bed Mobilization
6. Emergency Management and Reporting
7. Continuous Monitoring and Feedback
Control group
This group will contiue with home care services by Health Ministriy ot Turkiye
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Training about Electronic Decision Support System
1. System Registration and Usage
2. Pressure Ulcer Prevention
3. Urinary Infection Prevention
4. Nutrition and Hydration Management
5. Physical Activity and In-Bed Mobilization
6. Emergency Management and Reporting
7. Continuous Monitoring and Feedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients with a total Barthel Index score of 0-20 (fully dependent) and 21-61 (severely dependent).
3. Caregivers who are familiar with using mobile devices and voluntarily agree to participate.
Exclusion Criteria
2. Patients with an acute medical condition (e.g., hospitalization due to infection or newly developed severe illness).
3. Caregivers with cognitive or technological limitations preventing
4. Caregivers who are not literate in Turkish and unable to use the application.
5. Terminal-stage patients\* with a life expectancy of a short period.
6. Caregivers with severe cognitive impairment (e.g., advanced-stage dementia) or untreated psychiatric disorders (e.g., schizophrenia).
7. Patients without an informal caregiver providing care at home.
8. Patients with an existing urinary infection based on hospital urinalysis records.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akdeniz University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sebahat Gozum
Prof.Dr.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Yusuf Güver, PhDc
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TBAEK-257
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.